Alps Advisors Inc. Raises Stock Holdings in Amdocs Limited $DOX

Alps Advisors Inc. raised its holdings in shares of Amdocs Limited (NASDAQ:DOX) by 11.6% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 237,883 shares of the technology company’s stock after purchasing an additional 24,771 shares during the quarter. Alps Advisors Inc. owned 0.21% of Amdocs worth $19,518,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the business. William Blair Investment Management LLC grew its position in shares of Amdocs by 2.4% during the second quarter. William Blair Investment Management LLC now owns 5,650 shares of the technology company’s stock worth $516,000 after buying an additional 133 shares in the last quarter. Mutual Advisors LLC grew its holdings in Amdocs by 3.2% during the 2nd quarter. Mutual Advisors LLC now owns 4,516 shares of the technology company’s stock worth $397,000 after acquiring an additional 138 shares in the last quarter. MGO One Seven LLC grew its holdings in Amdocs by 5.1% during the 2nd quarter. MGO One Seven LLC now owns 2,899 shares of the technology company’s stock worth $264,000 after acquiring an additional 140 shares in the last quarter. Huntington National Bank raised its stake in shares of Amdocs by 5.0% in the 2nd quarter. Huntington National Bank now owns 3,273 shares of the technology company’s stock valued at $299,000 after purchasing an additional 155 shares in the last quarter. Finally, Scotia Capital Inc. raised its stake in shares of Amdocs by 3.9% in the 2nd quarter. Scotia Capital Inc. now owns 4,144 shares of the technology company’s stock valued at $378,000 after purchasing an additional 156 shares in the last quarter. 92.02% of the stock is owned by institutional investors and hedge funds.

Amdocs Price Performance

Shares of DOX opened at $73.34 on Monday. Amdocs Limited has a 12 month low of $70.24 and a 12 month high of $95.41. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.06 and a quick ratio of 1.17. The stock has a fifty day moving average price of $80.15 and a 200 day moving average price of $82.29. The company has a market cap of $7.92 billion, a P/E ratio of 14.19, a PEG ratio of 1.30 and a beta of 0.40.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.75 by $0.06. The company had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.15 billion. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The company’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.66 earnings per share. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. On average, research analysts forecast that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Tuesday, March 31st will be issued a dividend of $0.569 per share. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.1%. This is a boost from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date of this dividend is Tuesday, March 31st. Amdocs’s dividend payout ratio is presently 40.81%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Wall Street Zen upgraded Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday. Barclays decreased their target price on Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research report on Wednesday. Bank of America lowered their price target on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a report on Wednesday, November 12th. Weiss Ratings restated a “hold (c)” rating on shares of Amdocs in a research note on Tuesday, January 27th. Finally, Wolfe Research reiterated a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $92.33.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.